During the past decade, Royal Cornwall Hospital Truro Sunrise Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Royal Cornwall Hospital Truro Sunrise Centre" are "Metastatic Merkel Cell Carcinoma" (1 trials) and "Squamous Cell Carcinoma of the Anal Canal" (1 trials). Many other conditions were trialed in "Royal Cornwall Hospital Truro Sunrise Centre" in a lesser frequency.

Most popular intervention types in "Royal Cornwall Hospital Truro Sunrise Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Retifanlimab" (1 trials), "carboplatin" (1 trials), "paclitaxel" (1 trials) and "retifanlimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Cornwall Hospital Truro Sunrise Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Royal Cornwall Hospital Truro Sunrise Centre". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Royal Cornwall Hospital Truro Sunrise Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Cornwall Hospital Truro Sunrise Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".